Susceptibilities of HIV-1 isolates derived from patients treated with didanosine and stavudine in combination

Antiviral Therapy

Volumn 2, Issue SUPPL.3, 1997, Pages 95-97

  Coakley, Eoin ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; STAVUDINE;

ANTIVIRAL ACTIVITY; ARTICLE; DRUG RESISTANCE; DRUG SENSITIVITY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL;

EID: 0031465949     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. D'Aquila R, Johnson V, Welles S, Japour A, Kuritzkes D, DeGruttola V, Reichelderfer P, Coombs R, Crumpacker C, Kahn J & Richman D. Zidovudine resistance an d human immunodeficiency virus type 1 disease progression during antiretroviral therapy. Annals of Internal Medicine 1995; 122:401-108.
2. Shafer R, Inversen A, Winters M, Aguiniga E, Katzenstein D & Merigan T. Drug resistance and heterogenous long-term virologie responses of human immunodeficiency virus type-1 infected subjects to zidovudine and didanosine, combination therapy. Journal of Infectious Diseases 1995; 172:70-78.
3. Pollard R, Peterson D, Hardy D, Pedneault L, Rutkiewicz V, Pottage J, Murphy R, Gathe J, Beal G, Skovronski J, Cross A & Dunkle L. Stavudine (D4T) and didanosine (DDI) combination therapy in HIV infected subjects: antiviral effect and safety in an ongoing pilot randomized double-blinded trial, 11th International Conference on AIDS, July 1996, Vancouver, BC, Canada. Abstract Th. B. 293.
4. The ACTG Virology Technical Advisory Committee and the Division of AIDS, NIAID. The ACTG Virology Manual for HIV laboratories. NIH publication No. 3828, 1994.
5. Inversen A, Schafer R, Wehrly K, Winters M, Mullins J, Chesebro B & Merigan T. Multidrug-resistant human immunodeficiency virus type-1 strains resulting from combination antiretroviral therapy, journal of Virology 1996; 70:1086-1090.
6. Lin P, Samanta H, Rose R, Patick A, Trimble J, Bechtold C, Revie D, Kahn N, Fcderici M, Li H, Lee A, Andersen R & Colonno R. Genotypic and phenotypic analysis of human immunodeficiency virus type 1 isolates from patients on prolonged stavudine therapy. Journal of Infections Diseases 1994; 170:1157-1164.
7. Hitchcock M. In vitro antiviral activity of didanosine compared with that of other dideoxynucleoside analogs against laboratory strains and clinical isolates of human immunodeficiency virus. Clinical Infections Diseases 1993; 16(Supplement 1):S16-S21.
8. St Clair M, Martin JL, Tudor-Williams G, Bach M, Vavro C, King D, Kellam P, Kemp S & Larder B. Resistance to DDI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase. Science 1991; 253:1557-1559.